Skip to content
WeighLab
Menu
Ranked #60 · Grade C

SkinnyRx review

Publishes a complete four-term ladder for both molecules — and advertises only the rung that costs a year up front, at $199 against a month-to-month rate of $349.

Visit SkinnyRx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$349/mo month-to-month ($299 on 4 months, $249 on 6, $199 only on 12)
Tirzepatide
$399/mo month-to-month ($349 on 4 months, $329 on 6, $299 only on 12)
Coverage
Most states
Brand-name
Compounded only

Semaglutide · modeled / year

$4,188

Tirzepatide · modeled / year

$4,788

Pricing verified August 2026

The Index scorecard

SkinnyRx scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month62/100
Price Transparency84/100
Nationwide Access82/100
Formulation Options62/100
Clinical Oversight66/100
Contract Flexibility58/100

Where the value is

  • A complete four-term ladder for both molecules is published rather than gated, so the cost of not committing is knowable before signup
  • Both compounded molecules are offered, with the same term structure on each
  • The twelve-month rate is genuinely low for the category if a year is a commitment you were going to make anyway

The tradeoffs

  • The '$199/month' it advertises everywhere is the TWELVE-MONTH rung. The rate you can stop after a month is $349 — 75% higher — and the figure appears without that term attached
  • An FDA warning letter is on public record against Lean Rx, Inc. dba SkinnyRx, issued 20 February 2026. We disclose it and we do not treat it as disqualifying
  • Brand names appear in its catalog with no purchasable price behind them — shown, not sellable
  • Compounded semaglutide and tirzepatide are not FDA-approved products

The bottom line

Best for: Shoppers who have already decided on a long commitment and want the term priced openly rather than hidden behind an intake — not price-first shoppers comparing on the advertised figure. Publishes a complete four-term ladder for both molecules — and advertises only the rung that costs a year up front, at $199 against a month-to-month rate of $349.

Ranked #60 of 529 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 528 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to SkinnyRx.

The 18 programs nearest this one

Pricing, states and verification reflect SkinnyRx's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on SkinnyRx's site. Not medical advice; see our disclosure.

← Back to the value leaderboard